Abbott India Ltd.

Financial

	Abbott India	Alkem Laboratories	Cipla
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	8.3 %	7.9 %	8.9 %
R&D as a % of Total Sales	0.02 %	3.3 %	6.1 %
Financials
5 yr Average ROE	26.29 %	16.74 %	11.43 %
5yr average Equity Multiplier	1.46	1.42	1.39
5yr Average Asset Turnover Ratio	1.18	0.9	0.76
5yr Avg Net Profit Margin	15.35 %	13.14 %	10.96 %
Price to Book	18.06	5.87	4.56
P/E	49.0	36.72	30.51
5yr Avg Cash Conversion Cycle	-44.73 Days	0.57 Days	-3.69 Days
Inventory Days	51.2 Days	55.43 Days	59.85 Days
Days Receivable	20.12 Days	40.86 Days	44.13 Days
Days Payable	107.05 Days	116.85 Days	114.64 Days
5yr Average Interest Coverage Ratio	119.35	24.09	23.71
5yr Avg ROCE	34.73 %	22.27 %	15.24 %
5yr Avg Operating Profit Margin	22.64 %	19.27 %	22.51 %
5 yr average Debt to Equity	0.0	0.22	0.13
5yr CAGR Net Profit	16.09 %	5.29 %	12.9 %
5yr Average Return on Assets	18.03 %	11.73 %	8.36 %
Shareholdings
Promoter Holding	74.99 %	56.74 %	33.47 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.42 %	-3.26 %
Change in Mutual Fund Holding (3 Yrs)	4.35 %	5.03 %	2.19 %

Business

	Abbott India	Alkem Laboratories	Cipla
Product Wise Break-Up	Product Wise Break-Up Anti Diabetic 42.82 Gastro Intestinal 25.46 Central Nervous System (CNS) 12.65 Hormones 11.59 Women`s health 7.48 Vitamin, Minerals & Nutrition 0 Hepatoprotectives 0 Respiratory 0 Vaccines 0 cardiovascular system 0 Derma 0 Anti-Infectives 0 Metabolic 0 Pain 0 Pharmaceutical 0 New ventures 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceuticals 0 Anti Diabetic 0 Gastro Intestinal 0 Vaccines 0 Women`s health 0 Central Nervous System (CNS) 0 Hormones 0 Hepatoprotectives 0 Derma 0 cardiovascular system 0 Anti-Infectives 0 Metabolic 0 Pharmaceutical 100.0 Pain 0 Vitamin, Minerals & Nutrition 0 Respiratory 0 New ventures 0	Product Wise Break-Up Pharmaceutical 95.78 Anti Diabetic 0 Gastro Intestinal 0 Vaccines 0 Women`s health 0 Central Nervous System (CNS) 0 Hormones 0 Hepatoprotectives 0 Derma 0 cardiovascular system 0 Anti-Infectives 0 Metabolic 0 Pharmaceutical 0 Pain 0 Vitamin, Minerals & Nutrition 0 Respiratory 0 New ventures 4.22
Location Wise Break-Up	Location Wise Break-Up India 98.67 Rest of the World 1.33 USA 0 SAGA 0 Europe 0 Global API 0 Emerging Markets 0 North America 0	Location Wise Break-Up North America 0 India 67.17 Global API 0 Emerging Markets 0 Rest of the World 0 Europe 0 USA 30.81 SAGA 0 Others 2.02	Location Wise Break-Up North America 29.0 India 44.0 Global API 2.0 Emerging Markets 0 Rest of the World 11.0 Europe 0 USA 0 SAGA 12.0 Others 2.0
Acute vs Chronic	Acute vs Chronic Chronic 46.0 Acute 27.0 Sub-chronic 27.0	-	-
Dosage Form Break-Up	Dosage Form Break-Up Injectable 39.89 Tablet 39.17 Liquids 15.9 Capsule 3.47 Ointment 0.27 Granules 0.23 Powder 0.19 Others 0.88	-	-
Brand Wise Break-Up	Brand Wise Break-Up Mixtard 19.93 Thyronorm 14.04 Ryzodeg 11.83 Udiliv 11.03 Novomix 9.31 Duphaston 8.88 Duphalac 6.69 Vertin 6.67 Novo Rapid 5.92 Cremaffin Plus 5.69 Claribid 0 Cremaffin 0 Similac 0 Ensure 0 Others 0.01	-	-

Abbott India Ltd.

SIGN UP FOR FREE